Search bioRxiv⌕ Search

Biology subjects

Ravera, F.

Publications and source records attributed to Ravera, F..

3 recordsLinked to original sources

Causal inference and functional dynamics of a visuomotor network demonstrate excitatory/inhibitory alterations in Multiple Sclerosis

Balanced excitation and inhibition are essential for brain dynamics, and their disruption can lead to network dysfunction in neurological diseases. Here, we present a conceptually unified multiscale brain modelling framework combining Dynamic Causal Modelling (DCM) applied to task and resting-state functional Magnetic Resonance Imaging (fMRI) data and The Virtual Brain (TVB) to characterise the excitatory/inhibitory balance of the brain. We applied the framework to a visuomotor brain subnetwork in a cohort of 9 healthy controls and 17 people with multiple sclerosis (pwMS). Acquired data included an event-related task fMRI experiment with variable grip force, resting-state fMRI, and diffusion-weighted imaging. The visuomotor network comprised the bilateral primary visual cortex (V1), left primary motor cortex (M1), supplementary motor and premotor cortex (SMAPMC), cingulate cortex (CC), superior parietal lobule (SPL), and right cerebellar lobule VI (CR). Results from DCM showed that while the overall network architecture was preserved in MS, there were significant alterations in the excitatory/inhibitory nature of effective connectivity: at rest, a statistical change was observed in CR-to-V1 connectivity, which was inhibitory in healthy volunteers but excitatory in MS. During task, effective connectivity feedback, including cerebellar self-connection, was positive in healthy volunteers but negative in MS and became increasingly dysregulated with higher motor demand. Alterations in functional and effective connectivity were associated with behavioural performance (task reaction time) and clinical measures (disability severity). At the overall group level, TVB parameters linked reduced NMDA-mediated excitatory gain to slower task responses. Moreover, integrating DCM and TVB demonstrated that higher global excitatory gain was associated with stronger task-engaged effective connectivity across sensorimotor and visuomotor pathways, linking network-level excitability captured by TVB to context-dependent reconfiguration of directed interactions and to connection-level strength revealed by DCM.

neuroscience↗

The role of eye movements in the process of silicone oil emulsification after vitreoretinal surgery

BackgroundEmulsification of silicone oil (SO) is a feared and common complication of SO tamponade as potentially associated with significant risks to ocular health, including elevated intraocular pressure (IOP), glaucoma, corneal and retinal changes. The aim of this study was to investigate the role and interplay of major factors on the formation of SO emulsion, such as eye rotations and albumin, a blood serum protein known to affect interfacial properties. MethodsExperiments were conducted in a realistic model of the vitreous chamber, filled with SO and an aqueous solution containing different concentrations of albumin. The model was subjected to harmonic and saccadic rotations, at body temperature. ResultsNo emulsions were detected in the absence of endogenous proteins in the aqueous solution. The presence of albumin significantly influenced emulsion formation, acting as a surfactant. Mechanical energy from eye movements was also found to contribute to emulsification, with higher mechanical energy provided to the system leading to smaller droplet sizes. The emulsions formed were stable over extended times. ConclusionsThis study highlights the complex interplay of factors influencing SO emulsification in the vitreous chamber. A better understanding of the mechanisms underlying SO emulsification is crucial for developing strategies to mitigate SO emulsion and the related complications.

biophysics↗

Biological modifications of the immune response to COVID-19 vaccine in patients treated with anti-CD20 agents and immune-checkpoint inhibitors

Investigating the impact of immune-modulating therapies on mRNA vaccine efficacy transcends the immediate context of the COVID-19 pandemic. This study focuses on the differential immune responses to the third dose of COVID-19 mRNA vaccine among healthy volunteers, cancer patients treated with immune-checkpoint inhibitors (ICIs), and those treated with the anti-CD20 antibody rituximab. Utilizing RNA sequencing, serology, and interferon-{gamma} release assessment, we charted the temporal dynamics of the immune response in such cohorts. Our findings indicate that ICIs maintain an immune profile similar to that of healthy individuals, whereas treatment with rituximab is associated with impairment of type I interferon response and the upregulation of transcripts pertaining to regulatory T cells, with a global dysfunction of both humoral and cellular immunity. This research deepens our understanding of the sophisticated interplay within the immune system in health and disease states, potentially informing therapeutic strategies across a spectrum of immunological conditions. Significance statementOur study examines how cancer treatments that modify the immune system affect transcriptional, serological, and cellular responses to a model for repeated antigenic stimulation in humans, represented by the SARS-CoV-2 booster vaccine. Specifically, we investigated patients treated with rituximab (RTX), which impairs antibody production, and immune checkpoint inhibitors (ICI), which can trigger autoimmune disorders. We discovered that RTX-treated patients not only exhibit a reduced antibody response but actually show a diminished interferon-mediated immune response, indicating a broader immune disruption than anticipated. Conversely, ICI-treated patients responded to the vaccine similarly to healthy individuals, suggesting that fears of adverse vaccine reactions in these patients may be unfounded. This research highlights important considerations for the clinical management of cancer patients receiving these treatments.

immunology↗